Contact Information
Company Information
Company
Cour Pharmaceuticals Development Co., Inc.
Total Funding
135169251.0
Technologies
Outlook
Microsoft Office 365
Google Cloud Hosting
Nginx
Shutterstock
Google Font API
WordPress.org
Mobile Friendly
Google Tag Manager
Circle
Remote
Keywords
pharmaceuticals
immunology
nanomedicine
immune tolerance
inflammation
nanotechnology
pharmaceutical manufacturing
immune reprogramming
antigen-specific tolerance
immune-mediated disease
biodegradable nanoparticles
clinical trials
autoimmune therapies
cnp-103
type 1 diabetes treatment
cnp-104
primary biliary cholangitis
cnp-106
myasthenia gravis
nanoparticle technology
therapeutic efficacy
fda clearance
therapeutic advancement
cnp-101
celiac disease
immune function preservation
preclinical studies
targeted delivery
immune modulation
monocyte targeting
adaptive immune response
t regulatory cells
genetic autoimmune disorders
gliadin encapsulation
immunotherapy
clinical efficacy
immunosuppressive therapies
disease-specific antigens
t-cell deletion
pharmaceutical innovation
immune deficiency
therapeutic collaboration
licensed programs
immune response management
disease progression
medical partnerships
research collaboration
dynamic immune therapy
novel drug development
cancer prevention
nutritional deficiencies
vaccine development
immune health
chronic illness management
medical
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans